Medable Reports 80% Revenue Growth from Portfolio-Level eCOA Adoption, Sharp Increase Compared to Study-by-Study Adoption
Growing industry confidence drives shift in digital strategy for clinical trial sponsorsPALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., a leading provider of clinical development technology, today announced 80% revenue growth in 2024 across enterpri...